Crossref
MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth
European Journal of Cancer · 2026-11 · 248 · 117596
DOI: 10.1016/j.ejca.2026.117596 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von N. Badesra.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Badesra, N. (2026). MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth. European Journal of Cancer, 248, 117596. https://doi.org/10.1016/j.ejca.2026.117596
Vancouver
Badesra N. MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth. European Journal of Cancer. 2026;248:117596. doi:10.1016/j.ejca.2026.117596
BibTeX
@article{Badesra2026,
author = {Badesra, N.},
title = {MJ34, a novel GSK3β inhibitor, restores autophagic flux and suppresses breast cancer growth},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117596},
doi = {10.1016/j.ejca.2026.117596}
}
EUVIMED